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Ultraviolet (UV) radiation is a potent human carcinogen 
and it induces skin cancer in experimental animals. 
Recent studies have shown that unique mutations in the 
p53 tumor suppressor gene contribute to the development 
of human and mouse UV-induced skin cancers. Such 
mutations are also found in sun-damaged skin and actinic 
keratosis, suggesting that p53 mutations arise early during 
UV skin carcinogenesis. Our studies have shown that p53 
mutations can be detected in UV-irradiated mouse skin 
months before the gross appearance of skin tumors, 
suggesting that p53 mutations can serve as a surrogate 
UV RADIATION AND SKIN CANCER 
Epidemiologic studies indicate that chronic exposure to ultraviolet 
(UV) radiation present in sunlight is responsible for the induction 
of most nonmelanoma skin cancer in humans. Wavelengths in the 
UVB (290-320 nm) region of the solar spectrum are absorbed into 
the skin, producing erythema , burns, and eventually skin cancer 
(parrish et ai, 1982; Kligman and Kligman, 1986; Gilchrest, 1990; 
Young, 1990; Kripke, 1991). UV radiation is a complete carcinogen 
as it does not require additional substances as initiators or promoters. 
The first step in skin carcinogenesis by UV involves the induction 
of DNA damage [cyclobutane pyrimidine dimers, pyrimidine (6-4) 
pyrimidone photoproducts, and other minor lesions], which then 
leads to a cascade of events including DNA repair, mutation, and 
transformation. Efficient removal of DNA lesions by cellular repair 
processes appears to be a critical step in the prevention of tumor 
formation. For example, xeroderma pigmentosum patients are 
deficient in their ability to repair pyrimidine dimers and are 
hypersensitive to sunlight and prone to the development of skin 
cancer (Robbins, 1988; Cleaver and Kraemer, 1989). Occasional 
errors during the repair of these lesions lead to the incorporation 
of wrong bases into the genetic material. The unrepaired lesions 
may also disrupt cellular processes by obstructing the DNA and 
RNA synthesizing machineries and introduce wrong bases into the 
DNA. These types of mistakes often result in mutation leading to 
loss or inappropriate expression of the affected genes. Among several 
genes investigated, the p53 tumor suppressor gene is by far the 
most frequently affected gene in human and mouse UV-induced 
skin cancers (Nataraj et aI, 1995; Brash et ai, 1996). 
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early biologic endpoint in skin cancer prevention studies. 
Indeed, application of sun protection factor 15 sunscreens 
to mouse skin before each UV irradiation resulted in an 
88-92% reduction in the number of p53 mutations. 
Because p53 mutations represent an early essential step 
in photocarcinogenesis, these results imply that inhibition 
of this event may protect against skin cancer develop­
ment. Key words: sunlightlphotocardnogenesisltumor sup­
pressor genelphotoprotection. The Journal of Investigative 
Dermatology Symposium Proceedings 3:52-56, 11)1)8 
p53 MUTATIONS IN UV-INDUCED SKIN CANCERS 
Several studies have shown that inactivation of the p53 tumor suppressor 
gene plays an important role in the development of human and mouse 
UV-induced skin cancers. p53 codes for a DNA binding protein 
involved in gene transcription and control of the cell cycle (reviewed 
in Levine, 1997). Normally, a very small amount of p53 protein is 
present in cells; in response to DNA damage, however, the protein 
accumulates, cell division is inhibited, and DNA repair occurs. It is 
thought that inhibition of cell division enables the cell to repair 
damaged DNA before undergoing replication. p53 is also involved in 
apoptosis, and it has been proposed that p53 serves as a "guardian of 
the genome" (Lane, 1992) by aiding DNA repair or causing elimination 
of cells with excessive DNA damage. The p53 gene is a common 
target for genetic alteration in human and mouse cancers, and often 
specific carcinogens induce specific types of mutation in this gene. 
Loss or mutation of p53 has been demonstrated in about 50% of all 
cancers examined, although the frequency of mutation varies gready 
depending on the type of cancer (Hollstein et ai, 1991). Mutation or 
loss of p53 disrupts the tumor suppressive functions of the protein, 
and in some cases, actively contributes to uncontrolled proliferation 
(Hinds et ai, 1989). 
Analyses of human skin cancers and UV-induced mouse skin cancers 
for p53 mutations have provided new insights into the molecular 
mechanisms by which UV radiation induces skin cancer. Studies by 
Brash et al (1991) revealed C-7T and CC-7TT transition mutations 
in the p53 gene in 58% of human SCc. Because UV radiation induces 
predominantly two types of lesions, cyclobutane pyrimidine dimers 
and (6-4) photoproducts, it is likely that these lesions give rise to 
C-7T or CC-7TT transitions. Mutations observed at dipyrimidine 
sites, especially C-7T or CC-7TT transitions, are caused by UV 
radiation and as such these mutations are termed "UV signature" 
mutations. In contrast, when the p53 mutational spectra in other types 
of human cancers are examined, the proportion of CC-7TT double 
transitions is negligible. In the last few years, UV-speciflc p53 mutations 
have been found in over 90% ofSCC and 50% of basal cell carcinoma 
(reviewed in Nataraj et ai, 1995; Brash et ai, 1996). p53 mutations have 
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also been found with high frequency in skin cancers from patients 
with xerodenna pigmentosum (Dumaz et ai, 1993; Sato et ai, 1993). 
The majority of these mutations are CC�TT tandem base substitutions, 
and most occur on the nontranscribed strand of DNA, implying 
preferential repair of UV-induced lesions on the transcribed strand. 
Analogous to human skin cancers, UV-induced mouse skin cancers 
also display p53 mutations (Kress et ai, 1992; Kanjilal et ai, 1993; 
Dumaz et ai, 1997; Ananthaswamy et ai, 1998), although the frequency 
of mutations and the exons in which they occur differ among mouse 
strains, for reasons that are not yet clear. For example, in our study, 
p53 mutations were detected at 70-100% frequency in UV-induced 
SKH-hr1 and C3H mouse skin tumors, respectively (Kanjilal et ai, 
1993; Ananthaswamy et ai, 1988). In contrast, 20% ofSCC from SKH­
I/hr hairless mice and 50% of SCC from BALB/C mice exhibited 
p53 mutations in another study (Kress et ai, 1992). Nonetheless, most 
of the mutations detected in UV-induced mouse skin tumors were 
C�T and CC�TT transitions at dipyrimidine sites, like those found 
in human skin cancers, and most were located on the nontranscribed 
DNA strand. 
TIME OF APPEARANCE OF p53 MUTATIONS IN SKIN 
CANCER 
Recent studies have shown that mutations in the p53 gene preceeds 
the appearance of skin cancer. For example, p53 mutations have been 
detected in sun-exposed skin from nonnal and skin cancer patients , 
and it can serve as an indicator of prior solar exposure in humans 
(Nakazawa et ai, 1994; Urano et aI, 1995; Ouhtit et ai, 1997). Our 
studies showed that noncancerous skin adjacent to skin cancers harbors 
p53 mutations distinct from those present in the skin cancers (Kanj ilal 
et ai, 1995). In addition, UV-specific p53 mutations were found in 
actinic keratoses (Nelson et ai, 1994; Ziegler et ai, 1994; Ren et ai, 
1996); normal skin flanking the actinic keratoses also contained a small 
number of p53 mutations (Ziegler et ai, 1994; Ren et aI, 1996), 
suggesting that actinic keratoses represent clonal proliferations of cells 
containing p53 mutations. Berg et al (1996) analyzed UVB-irradiated 
mouse skin for the presence of cells expressing mutant p53 protein 
and found several clusters of cells in the epidermis that reacted with 
an antibody specific for mutant p53 protein after 17 or 30 daily UVB 
exposur�s, which would cause skin tumors around 80 or 30 wk, 
respectively. Such clusters expressing the mutant p53 protein persisted 
in the skin for at least 56 d after UVB irradiation. More recently, 
Jonason et al (1996) demonstrated that whole mount preparations of 
human skin contain clonal patches of p53-mutated keratinocytes. Such 
patches were larger and more frequent in sun-exposed skin than in 
sun-protected skin. It is estimated that these clonal patches represent 
as much as 4% of the epidermis . These results demonstrate that p53 
mutations are causally related to UVB exposure and that they arise 
very early during skin cancer development. 
Experiments to determine the timing of p53 mutation in relation 
to skin cancer development have been perfonned in the mouse model 
of photocarcinogenesis because this model is quite amenable to UV 
irradiation and sample collection at various time points during the 
carcinogenesis protocol (Ananthaswamy et ai, 1997). One of the 
objectives of this study was to determine when during UV skin 
carcinogenesis p53 mutations arise. In this study, we exposed shaved 
dorsal skin of C3H mice to UVB radiation from a bank of Kodacel­
filtered FS40 sunlamps five times per week at a dose of 4.5 kJ per m2 
per exposure until all the mice developed skin tumors. At monthly 
intervals, UV exposed epidermis was analyzed for p53 mutation. In 
contrast to tumor tissues in which mutant p53 alleles are expected to 
be present at very high frequencies, the frequency of mutations in 
UV-irradiated skin is expected to be very low because mutations are 
present in only a small fraction of the overall cell population. Because 
of this problem, detection of p53 mutations in UV-irradiated skin by 
conventional procedures is rather difficult. We therefore developed 
sensitive techniques involving allele-specific polymerase chain reaction 
and single-strand conformation polymorphism (SSCP) to screen for 
p53 mutation. In addition, we targeted tandem CC�TT mutations at 
specific codons known to be mutated in UV-induced mouse skin 
SUNSCRllENS INHmlT UV-INDUCED p53 MUTATIONS S3 
Table I. pSJ mutations in UVB-irradiated mouse skin" 
UV(wk) 
4 
8 
12 
16 
No. of mice with mutations/no. of mice analyzed 
Codons 154-155 
0/10 
2/10 
2/10 
2/9 
Codons 175-176 
1/10 
2/10 
3/10 
2/9 
Total 
1/10 
4/10 
5/10 
4/9 
'Epidennal DNA was extracted from unirradiated .nd UV-irradi.ted mouse skin .nd 
analyzed for p53 mutation by allele-specific polymer.se ch.in re.ction and SSCP. None 
of the unirr.diated mouse skin samples contained a p53 mutation. Reprinted by pemUssion 
of Cadmus Joumal Services from Ananthaswamy et al (1997). 
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Figure 1. Time course for induction of p5J mutation and skin cancer 
in UV-irradiated C3H mouse skin. UV-irradiated mouse skin was analyzed 
for p53 mutation from the fourth to the sixteenth week of chronic irradiation. 
The [nice were monitored weekly for tumor development. Each point represents 
d.1ta from 10 mice for p53 mutation and from 30 mice for skin cancer. 
Reprinted by permission of Cadmus Journal Services from Ananthaswamy 
et aT (1997). 
cancers. We found previously that UV-induced mouse skin cancers 
contain tandem CC�TT mutations at codons 148, 154-155, or 175-
176 (Kanjilal et ai, 1993; Ananthaswamy et ai, unpublished data). By 
using allele-specific primers for these codons, we amplified genomic 
DNA from UV-irradiated mouse skin by polymerase chain reaction 
and the products were subjected to SSCP analysis . By this approach, 
we were able to detect p53 mutations in mouse skin as early as the 
fourth week of UV irtadiation (Table I), and the frequency of p53 
mutations increased progressively and reached 50% at 12 wk of chronic 
UV exposure (Fig 1). The p53 mutation frequency is probably much 
higher than we observed here because we only targeted tandem 
CC�TT mutations. In UV-induced mouse skin cancers, C�T 
transitions comprise about 70% of the mutations in p53, whereas 
CC�TT mutations constitute only 10-20% of these mutations. Thus, 
the actual mutation frequency is probably 5- to lO-fold higher than 
what we observed. 
Nonetheless, around week 16, when the p53 mutation frequency 
reached maximum, the first mouse developed a skin tumor, and 50% of 
the mice developed skin cancer by week 25 (Fig 1). All tumors were 
histologically confinned squamous cell carcinomas, undifferentiated 
carcinomas, or fibrosarcomas. Analysis of some of these tumors for 
p53 mut�vealed typical C�T or CC�TT transitions in exons 
5-8, -sinlllar to those found in skin tumors induced by unflltered and 
Kodacel-flltered FS40 sunlamps (Kanjilal et ai, 1993; Ananthaswamy 
et ai, unpublished data). 
SUNSCREENS AND PHOTOPROTECTION 
As mentioned before, excessive exposure to sunlight causes damage to 
the skin, including erythema, edema, hyperplasia, fonnation of sunburn 
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cells, photoaging, suppression of the immune system, and skin cancer. 
In order to protect against some of the hamlful effects of sunlight, 
most lightly pigmented individuals are advised to use sunscreens with 
a sun protection factor (SPF) of 15 or greater. In fact, the use of 
chemical sunscreens has helped to reduce at least some of the deleterious 
effects of UV radiation on human skin. Although commercial 
sunscreens were originally developed to pwtect against sunburn, 
laboratory studies have shown that some sunscreens are also quite 
efficient in protecting against UV-induced DNA damage (Lowe and 
Breedings, 1980; Freeman et a11988; De Rijcke and Heenen, 1989; 
van Praag et ai, 1993; Wolf et aI, 1 993b ; Ley and Fourtanier, 1997), 
skin aging (Kligman et ai, 1982; Fourtanier et ai, 1992), sunburn cell 
formation (Wolf et ai, 1995), immunosuppression (Morison and Kelley, 
1984, 1985; Morison, 1984; Reeve et aI, 1991; Wolf et ai, 1993a, b, 
1995; Bestak et aI, 1995; Whitmore and Morison, 1995; Roberts et al, 
1996; Damian et ai, 1997; Walker and Young, 1997; Roberts and 
Beasley, 1995, 1997),1 and development of skin cancer (Kligman et ai, 
1980; Wulf et aI, 1982; Forbes et aI, 1989; Flindt-Hansen et ai, 1990; 
van Praag et aI, 1993; Fourtanier, 1996) in animal models . But the 
question of whether the sunscreens afford protection against skin cancer 
in humans remains an open question and has not been investigated in 
great detail, although studies have shown that sunscreens can prevent 
the emergence of actinic keratoses in humans (Naylor et aI, 1995) and 
,help reduce skin cancer risk in xeroderma pigmentosum patients 
(Kondoh et ai, 1994). In addition, epidemiollogic evidence suggests 
that comprehensive use of sunscreens may reduce the risk of skin 
cancer by 80% (Stem et ai, 1986). 
The relative effectiveness of sunscreens is generally evaluated on the 
basis of their ability to prevent erythema in human skin. Erythema 
provides a simple, noninvasive, rapid endpoint for measuring the 
attenuation of exposure to solar radiation by sunscreens; however, its 
ability to predict the protective effect of sunscreens on other endpoints 
ofUV exposure, such as skin cancer and immune suppression, depends 
on the similarities of the action spectra and threshold doses for these 
effects. Because the action spectra for skin cancer and immune 
suppression in humans are not established, it is IPossible that a sunscreen 
could protect against erythema and be relatively ineffective in protecting 
against immunosuppression or skin cancer. Therefore, it is desirable to 
develop other endpoints for measuring attenuation of UV radiation by 
sunscreens. Such endpoints might be more accurate predictors of the 
effectiveness of sunscreens in preventing skin cancer and immuno­
suppression . Furthermore, comparing them with erythema would help 
to assess the relevance of the erythema-based SPF for protection against 
photocarcinogenesis and immunosuppression. 
The use of cancer induction as an endpoint for assessing the 
effectiveness of sunscreen compounds in experimental animals , although 
ideal, is a labor-intensive, time consuming, Ilong-term endpoint. In 
addition, tumor induction cannot be studied readily in humans because 
of ethical considerations and the length of time involved. It is therefore 
important to develop other earlier endpoinlts that might be more 
accurate than erythema in predicting the effecltiveness of sunscreens in 
preventing skin cancer. In this regard, mutation of the p53 turnor 
suppressor gene may serve as a short-term molecular surrogate for the 
long-term biologic endpoint of skin cancer development because 
mutations in this gene have been shown to be a key component of 
the disease pathway, rather than merely a correlative marker. 
PROTECTION AGAINST UV-INDUCED pS3 MUTATIONS 
BY SUNSCREENS 
Our finding that p53 mutations arise early during UV skin carcino­
genesis suggests that it might be possible to use them as an early 
biologic endpoint for testing the efficacy of sunscreens in photo­
protection studies. We therefore applied SPF 115 sunscreens containing 
either UVB absorbers (10% Uvinul N-539, 2% Eusolex 232), UVB 
and UVA absorbers (9% Uvinul N-S39 , 0.3% Eusolex 232, 3% Parsol 
lLeVee GJ. Oberheiman L, Cowell K, Koren H, Cooper KD: Effect of 
sunscreen on humans immunosuppression by Simul:lted solar radiation. ] Invest 
Dermatol 104:600, 1995 (abstr.) 
JID SYMPOSrUM PROCEEDINGS 
1789, and 0.7% Mexoryl SX), or vehicle onto the shaved dorsal skin 
of C3H mice, 30 min before each exposure to UVB radiation. The 
International Cosmetic Ingredient Dictionary (1995) nanles for the UV 
absorbers are: Uvinul N-539, octocrylene ; Eusolex 232, phenyl­
benzimidazole sulfonic acid; Parsol 1789, butyl methoxydibenzoyl­
methane; Mexoryl SX, terephthalylidene dicamphor sulfonic acid. The 
vehicle for both preparations was an oil-in-water emulsion (10% 
silicone, 2% organic esters, and 15% polyols) . Mter 12 wk of treatment, 
we analyzed epidermal DNA for CC�TT mutations at codons 14B, 
154--155, and 175-176 by allele-specific polymerase chain reaction 
and SSCP. The results indicated the presence of p53 mutation at 
codons 148, 154--155, or 175-176 in nine of 20 mice exposed to 
vehicle + UV (Table II). On the other hand, only one of 20 of the 
UV-irradiated mice treated with UVB sunscreen and only two of 20 
of the UV-irradiated mice treated with UVB + A sunscreens contained 
mutations at these codons. When the total number of p53 mutations 
at codons 148, 154--155, and 175-176 was compared between these 
three groups, there were 24 mutations in the vehicle + UV group, 
and this number was reduced to three and two mutations, respectively, 
in the UV-irradiated groups treated the UVB sunscreen and the 
UVB + A sunscreens (Table II). 
The inhibition of p53 mutation by sunscreens can be attributed to 
their ability to protect the skin against UV-induced DNA damage . In 
fact, one of the UVA absorbers used in this study (MexOIyl SX) has 
recently been shown to protect against DNA damage (Ley and 
Fourtanier, 1997) and photo carcinogenesis in mice (Fourtanier, 1996), 
suggesting a correlation between these biologic endpoints and skin 
cancer induction. The UVB sunscreens used in this study appeared to 
be as effective as the UVB + A sunscreens in inhibiting p53 mutation. 
This finding was not unexpected because we only looked for UVB­
induced mutations (CC..-tTT) in UV-irradiated mouse skin and did 
not assess UVA-induced mutations, which are predominantly T..-tG 
transversions (Drobetsky et ai, 1995). Also, this type of UVA-induced 
mutation is not commonly found either in sunlight-induced human 
skin cancers or in UV-induced mouse skin cancers, suggesting that 
mutagenesis by UVA plays a minor role in photo carcinogenesis, 
although other nonmutational effects of UVA may contribute to the 
progression of skin cancer. The fact that both sunscreens inhibited 
UVB-induced p53 mutations in the mouse model suggests that these 
sunscreens may also afford protection against sunlight-induced p53 
mutation in human skin, thereby reducing the rate of skin cancer 
development . In this regard, it is worth mentioning that topical 
application of sunscreens to human skin nearly eliminated UV-induced 
expression of p53 and p21 proteins (EI-Deiry et ai, 1995; Ponten et aI, 
1995). In contrast to erythema that serves as an endpoint for protection 
against sunburn, p53 mutation may serve as an endpoint to detect an 
early, essential step in the multistep process of photo­
carcinogenesis. Thus, in addition to SPF, it may be possible to develop 
a mutation protection factor for sunscreens based on their ability to 
inhibit p53 mutation in a model system of photo carcinogenesis. 
FUTURE PROSPECTS 
Because UV-induced DNA damage, p53 mutation, proliferation, 
and immunosuppression are key events in skin cancer development, 
inhibition of one or more of these events may protect against skin 
cancer development (Fig 2). Some sunscreens afford protection against 
all these events because they interfere with the primary event, i.e., 
DNA damage , which is a prerequisite for p53 mutation and some 
types of immunosuppression. In addition to DNA damage, UV 
radiation can also isomerize urocanic acid present in the stratum 
corneum from the native trailS to the as form, which in tum causes 
immunosuppression in mice (Noonan and DeFabo, 1992); however, 
it is reported that although sunscreens can block UV-induced isomeriz­
ation of tra/'IS- to ds-urocanic acid, there was no apparant correlation 
between formation of cis-urocanic acid and suppression of contact 
hypersensitivity (Reeve et aI, 1994). Nonetheless, use of sunscreens 
alone may not be sufficient to prevent skin cancer development because 
the sunscreens must be applied bifore each exposure to sunlight, and 
must be reapplied every few hours or after coming into contact.with 
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Table II. Inhibition of p53 mutations in UV-irradiated mouse skin by sunscreensD 
No. of mice with mutations/no. of mice analyzed 
Total no. Per cent 
Treatment 148 154-155 175-176 Total mutations inhibition 
None 0/5 0/5 0/5 0/5 0 0 
Vehicle + UV 8/20b 7120" 9120& 9120b 24 0 
UVB sunscreen + UV 1120' 1/20' 1/20' 1120' 3d 88 
UVB + A sunscreen + UV 0120 2120 0120 2120 2d 92 
'Shaved dorsal skin of C3H mice was applied with SPF 15 sunscreens (100 iJl per mouse; "'2 mg per cm2) containing either UVB or UVB + A absorbers, and 30 min later the mice 
were exposed to UVB from a bank of Kodacel-ftItered FS40 sunlamps at a dose of 4.5 10 per m2• Epidemlal DNA was analyzed for p53 mutation by allele-specific polymerase chain 
reaction and SSCP. 
'Seven mice had all three mutatIOns, one mouse had both 148 and 175-176 mutations, and one mouse had only the 175-176 mutation. 
'The same mouse had all three mutations. 
'p < 0.005 verstls the vehicle + UV group (chi-square test). 
Reptinted by permission ofC.dmusJournal Services from Ananthaswamy el al (1997). 
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Figure 2. A Dmdel for key events in photocarcinogenesis and potential 
intervention points. See text for explanation. 
water. In addition, some individuals may not use any type of sunscreen 
when they are exposed to sunlight (recreational or occupational). 
Because of these limitations, it may be difficult to completely prevent 
events such as DNA damage and mutation that occur early during skin 
carcinogenesis. Thus in addition to the "morning before" lotions 
containing sunscreens, the use of "morning after" creams containing 
agents that enhance the repair of UV-induced DNA damage may 
abrogate key events in photo carcinogenesis such as immunosuppression 
and p53 mutation. In fact, recent studies have shown that enhancement 
of DNA repair ofUV-induced pyrimidine dimers by treatment ofUV­
irradiated mouse skin with liposomes containing T4N5 endonuclease 
or DNA photolyase, abrogated UV-induced suppression of contact 
hypersensitivity (reviewed in Vink et ai, 1996). In addition, application 
of gel extracts of Aloe barbadensis, a widely used ingredient in skin 
care products, to UV-irradiated mouse skin prevented UV-induced 
suppression of contact hypersensitivity (Strickland et ai, 1994); however, 
the mechanisms by which extracts of Aloe barbadensis overcome the 
immunosuppressive effects of UV are unknown. 
Finally, comprehensive skin cancer prevention programs should also 
include intervention strategies that are directed at later stages of UV 
skin carcinogenesis, such as preventing cells containing p53 mutation 
from progressing into a tumor or preventing secondary skin tumors. 
Development and use of novel drugs that induce differentiation or 
apoptosis of so-called "initiated cells" and premalignant lesions may 
provide new intervention strategies for the prevention of skin cancer. 
Numerous studies have shown that chemopreventive agents such as 
retinoids (Moon et aI, 1997), green tea polyphenols, silymarin (reviewed 
in Agarwal and Mukhtar, 1996), butylated hydroxy toluene, carotenoids 
(reviewed in Black and Mathews-Roth, 1991), and a low-fat diet 
(Black et ai, 1995) are quite effective in reducing the incidence ofUV­
induced skin cancers. Particularly, the use of retinoids may be more 
applicable or effective in reducing the number and severity of new 
skin cancers in high risk patients who present with single or multiple 
primary skin cancers (Rook et ai, 1995). We have invoked the 
hypothesis of "field cancerization" to explain the occurence of multiple 
primary cancers (Kanjilal et ai, 1995). According to this theory, 
entire regions of tissues or organs become genomically unstable and 
predisposed to aberrant growth as a result of prolonged exposure to 
carcinogens. The dysregulation of proliferation and differentiation in 
the "condemned" field is often associated with numerous premalignant 
lesions and a high incidence of multiple primary tumors. In addition, 
as the risk of developing skin cancer in the entire sun-damaged field 
remains high for several years, it is very important to block or reverse 
the progression of cells from "condemned" field to primary tumors. 
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